EPISODE · Aug 26, 2020 · 8 MIN
Covid-19 vaccine makers seek protections, US homebuilder stocks rise, Ant IPO
from FT News Briefing
European vaccine makers want EU exemptions that would protect them if there are problems with new Covid-19 vaccines, and low interest rates have helped US homebuilder stocks surge to record highs. Plus, the FT’s James Fontanella-Khan explains why Ant Group chose to list its potentially record setting IPO outside the US. Covid-19 vaccine makers lobby EU for legal protectionhttps://www.ft.com/content/12f7da5b-92c8-4050-bcea-e726b75eef4d?Low rates help propel US homebuilder stocks to record highshttps://www.ft.com/content/9b54ab06-2d57-44a1-85c2-47c114589c22Ant Group reveals $2.6bn profit as it files for blockbuster IPOhttps://www.ft.com/content/b5f6fed2-2dcf-48dc-9097-a49bff5532dc Hosted on Acast. See acast.com/privacy for more information.
What this episode covers
European vaccine makers want EU exemptions that would protect them if there are problems with new Covid-19 vaccines, and low interest rates have helped US homebuilder stocks surge to record highs. Plus, the FT’s James Fontanella-Khan explains why Ant Group chose to list its potentially record setting IPO outside the US. Covid-19 vaccine makers lobby EU for legal protectionhttps://www.ft.com/content/12f7da5b-92c8-4050-bcea-e726b75eef4d?Low rates help propel US homebuilder stocks to record highshttps://www.ft.com/content/9b54ab06-2d57-44a1-85c2-47c114589c22Ant Group reveals $2.6bn profit as it files for blockbuster IPOhttps://www.ft.com/content/b5f6fed2-2dcf-48dc-9097-a49bff5532dc Hosted on Acast. See acast.com/privacy for more information.
NOW PLAYING
Covid-19 vaccine makers seek protections, US homebuilder stocks rise, Ant IPO
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·13m
Apr 19, 2026 ·16m
Apr 17, 2026 ·13m
Apr 13, 2026 ·11m
Apr 11, 2026 ·16m